Magnolia Oil & Gas

MGY · NYSE

$25.46−$0.01 (−0.04%)TodayMarket closed ·
Prev close $25.47

MGY analyst rating

BuyConsensus of 19 analysts over the last 12 months. 63% rate it a buy.
  • Strong buy0
  • Buy12
  • Hold7
  • Underperform0
  • Sell0

12-month price target · 19 analysts

Average $33.60 (+32.0% upside)

Low
$27.27
Now
$25.46
High
$39.90

Upgrades and downgrades

The latest rating actions, newest first

MGY analyst upgrades, downgrades and rating actions
FirmDateActionRating
ScotiabankOct 15, 2026InitiatesSector Outperform
Wells FargoOct 14, 2026MaintainsEqual-Weight
Truist SecuritiesOct 2, 2026MaintainsBuy
Truist SecuritiesSep 21, 2026MaintainsBuy
JP MorganSep 8, 2026UpgradeNeutral → Overweight
Seaport GlobalSep 3, 2026InitiatesNeutral
Johnson RiceAug 17, 2026UpgradeHold → Accumulate
Wells FargoAug 13, 2026MaintainsEqual-Weight
CitigroupAug 11, 2026MaintainsNeutral
SusquehannaAug 11, 2026MaintainsPositive

The case for and against

Updated Oct 14, 2026

Bull case

Magnolia Oil & Gas is viewed favorably because its disciplined capital program supports steady 4% to 5% production growth while preserving a low reinvestment rate and strong cash generation. Its WildFire Energy acquisition adds 810,000 net acres in Giddings, lifts pro forma oil cut from 40% to 50%, extends inventory life to about 11 years, and is expected to be 13% accretive to 2027 CFPS. The company also shows financial strength with deleveraging ahead of schedule, about 1.0x net debt/EBITDA by 2027 under assumptions, a 12% free cash flow yield, and continued share repurchases that reinforce shareholder returns.

Bear case

Magnolia Oil & Gas is viewed negatively because its earnings and free cash flow remain highly exposed to volatile commodity pricing and geopolitics, and as a totally unhedged producer, a decline in oil or gas prices would quickly pressure returns and profitability. The recent $1.1B equity raise and higher leverage tied to the Wildfire transaction also weaken the financial setup, prompting a 3.5% cut to 2027 CFPS estimates and a lower valuation framework despite the deal being about 13% accretive. Even with a pristine balance sheet, operating in an emerging basin and the risk of M&A dilution or missed production targets create a less reliable outlook for steady shareholder value creation.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.